Rocket Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Rocket Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. 

CEO
Gaurav D. Shah
CEOGaurav D. Shah
Employees
299
Employees299
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
1999
Founded1999
Employees
299
Employees299

RCKT Key Statistics

Market cap
760.27M
Market cap760.27M
Price-Earnings ratio
-2.61
Price-Earnings ratio-2.61
Dividend yield
Dividend yield
Average volume
4.24M
Average volume4.24M
High today
$7.44
High today$7.44
Low today
$6.97
Low today$6.97
Open price
$7.21
Open price$7.21
Volume
3.26M
Volume3.26M
52 Week high
$26.98
52 Week high$26.98
52 Week low
$4.55
52 Week low$4.55

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.